Malignant Pleural Mesothelioma — Works 100%

Efforts are focused on blood-based screening for high-risk individuals (former asbestos workers).

A non-invasive device that uses electric fields to disrupt cancer cell division. Prognosis and Future Outlook malignant pleural mesothelioma

💡 While MPM remains a challenging malignancy, the shift from traditional chemotherapy toward personalized immunotherapy and lung-sparing surgery offers new hope for extending patient survival. Efforts are focused on blood-based screening for high-risk

Management typically involves a , combining several therapies to maximize efficacy. 1. Surgery malignant pleural mesothelioma

Historically, the median survival rate for MPM has been 12 to 18 months. However, the landscape is shifting:

Asbestos fibers induce reactive oxygen species (ROS), leading to DNA breaks and the silencing of tumor-suppressor genes. Classification and Pathology